The historical rank and industry rank for SS Innovations International's EV-to-OCF or its related term are showing as below:
SSII'
s EV-to-OCF Range Over the Past 10 Years
Min: -396.24 Med: -74.92 Max: -1.95
Current: -51.27
During the past 10 years, the highest EV-to-OCF of SS Innovations International was -1.95. The lowest was -396.24. And the median was -74.92.
SSII's EV-to-OCF is ranked better than 93.68% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: 7.7
vs SSII: -51.27
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
SS Innovations International (NAS:SSII) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
SS Innovations International's PE Ratio (TTM) for today is calculated as:
SS Innovations International's share price for today is $3.74.
SS Innovations International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.053.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
SS Innovations International EV-to-OCF Related Terms
SS Innovations International EV-to-OCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, SS Innovations International's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SS Innovations International EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SS Innovations International's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where SS Innovations International's EV-to-OCF falls into.
SS Innovations International's current Enterprise Value is $756.34 Mil.
SS Innovations International's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-14.75 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SS Innovations International (SSII) has a EV-to-OCF of -51.27 as of Jul. 11, 2026. According to the industry distribution chart, SS Innovations International ranks #54 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 6.3%.
Is SS Innovations International's EV-to-OCF too high?
SS Innovations International's current EV-to-OCF is -51.27. Based on the distribution chart, SS Innovations International ranks #54 out of 855 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, SS Innovations International has a GF Score™ of 41/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SS Innovations International's EV-to-OCF compare to BVS and TCMD?
According to the Medical Devices & Instruments industry distribution chart, SS Innovations International ranks #54 out of 855 companies for EV-to-OCF. This places SS Innovations International in the top 6% of its industry — outperforming the majority of peers. The industry median EV-to-OCF is 7.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.70, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SS Innovations International's current EV-to-OCF is -51.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SS Innovations International stock overvalued right now?
Based on GuruFocus' analysis, SS Innovations International (SSII) is currently considered Possible Value Trap. The stock's GF Value™ is $18.74, compared to a current price of $3.74 — trading 80% below its estimated fair value. The current EV-to-OCF is -51.27. SS Innovations International's overall GF Score™ is 41/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For SS Innovations International (SSII), the current EV-to-OCF is -51.27 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SS Innovations International (SSII) Overvalued in 2026?
Based on GuruFocus' analysis, SS Innovations International stock appears to be undervalued.
The current stock price of $3.74 is trading 80% below its estimated GF Value™ of $18.74.
GuruFocus considers SS Innovations International to be Possible Value Trap.
Key valuation signals for SSII:
EV-to-OCF: -51.27
GF Value™: $18.74 vs. price of $3.74 (80% below fair value)
No single metric tells the full story. See the SSII stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SS Innovations International Inc is a commercial-stage surgical robotics company. It designs, manufactures, and markets a surgical robotic system called the SSi Mantra Surgical Robotic System (the SSi Mantra) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic, and cardiac surgeries. Additionally, the company offers a suite of stapling, energy, and core instrumentation for its surgical systems, under the brand name of SSi Mudra.
41GF Score
Get the complete analysis for SSII
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SSII has been successfully added to your 
